Prediction: Lilly Will Reach $1,200 in 2026 — Investment Thesis
Eli Lilly’s GLP-1 drugs are redefining growth in obesity and diabetes treatment. This article lays out why the stock ...
Eli Lilly’s GLP-1 drugs are redefining growth in obesity and diabetes treatment. This article lays out why the stock ...
As AI accelerates software adoption, saas stocks rallying optimism could lift shares higher. This guide breaks down t...
In the AI boom, everyone chase chips and models. But the most important company you've probably never heard of sits b...
May payrolls came in at 172,000, keeping the Fed on hold for higher-for-longer rates. Bitcoin slid as borrowing costs...
Redwire’s backlog and contract wins are lifting the stock, but the company remains unprofitable. This report weighs t...
Walmart is turning growth from stores to a digital revenue engine. Advertising, memberships, and a thriving marketpla...
SpaceX has filed its S-1 ahead of a long-anticipated IPO, revealing a diversified, revenue-rich business anchored by ...
As oil markets wobble, a fee-based midstream leader stands out for steady cash flow and growing backlog. Investors ar...
A mid-career executive carved tax savings from a $480,000 severance by spreading payments across two years, illustrat...
Three long-time CBS News correspondents pledged to stay with the program amid a leadership shake-up, signaling a deli...
A former Republican congressman receives a presidential pardon from Trump, erasing insider-trading gains tied to a ma...
Former President Donald Trump said he would attend Game 3 of the NBA Finals but urged ordinary fans to stream it inst...